+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Doxil"

Doxorubicin Market Report 2025 - Product Thumbnail Image

Doxorubicin Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Liposomal Doxorubicin Market Report 2025 - Product Thumbnail Image

Liposomal Doxorubicin Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Liposomal Doxorubicin Market Report and Forecast 2025-2034 - Product Thumbnail Image

Liposomal Doxorubicin Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Doxil is a chemotherapy drug used to treat ovarian cancer. It is a liposomal formulation of the drug doxorubicin, which is an anthracycline antibiotic. Doxil is used to treat advanced ovarian cancer, as well as other types of cancer, such as breast cancer, Kaposi's sarcoma, and multiple myeloma. It is administered intravenously and works by interfering with the growth of cancer cells. Doxil is a widely used drug in the treatment of ovarian cancer, and is often used in combination with other drugs. It is generally well tolerated, with few side effects. Common side effects include nausea, vomiting, hair loss, and fatigue. The Doxil market is highly competitive, with several companies offering the drug. Some of the companies in the market include Janssen Pharmaceuticals, Sun Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more